This call for applications is to encourage animal model testing of the Malaria Box hit compounds and their derivatives in neglected infectious disease models, such as schistosomiasis, cryptosporidiosis, filariasis, tuberculosis, as well as other infections where there is comorbidity in children with malaria.
Priority will be given to proposals with investigators from malaria-endemic countries, who demonstrate their project will help support capacity building in disease endemic areas.
Please visit the Medicines for Malaria Venture website for detailed information.
All applications, using the templates on our website, should be sent electronically to: email@example.com
Submission deadline: 12 noon CET 30 October 2014